Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4850579
Max Phase: Preclinical
Molecular Formula: C39H61NO5
Molecular Weight: 623.92
Molecule Type: Unknown
Associated Items:
ID: ALA4850579
Max Phase: Preclinical
Molecular Formula: C39H61NO5
Molecular Weight: 623.92
Molecule Type: Unknown
Associated Items:
Canonical SMILES: C=C(C)[C@@H]1CC[C@]2(COC(=O)/C=C(\C)C(=O)N3CCOCC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
Standard InChI: InChI=1S/C39H61NO5/c1-25(2)27-11-16-39(24-45-32(42)23-26(3)34(43)40-19-21-44-22-20-40)18-17-37(7)28(33(27)39)9-10-30-36(6)14-13-31(41)35(4,5)29(36)12-15-38(30,37)8/h23,27-31,33,41H,1,9-22,24H2,2-8H3/b26-23+/t27-,28+,29-,30+,31-,33+,36-,37+,38+,39+/m0/s1
Standard InChI Key: YPBDSJYEXNBBNL-NSXAEVITSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 623.92 | Molecular Weight (Monoisotopic): 623.4550 | AlogP: 7.35 | #Rotatable Bonds: 5 |
Polar Surface Area: 76.07 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 6.84 | CX LogD: 6.84 |
Aromatic Rings: 0 | Heavy Atoms: 45 | QED Weighted: 0.20 | Np Likeness Score: 2.10 |
1. Pęcak P, Orzechowska B, Chrobak E, Boryczka S.. (2021) Novel betulin dicarboxylic acid ester derivatives as potent antiviral agents: Design, synthesis, biological evaluation, structure-activity relationship and in-silico study., 225 [PMID:34425312] [10.1016/j.ejmech.2021.113738] |
Source(1):